Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues. 2002

Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
Laboratório de Avaliação e Síntese de Substâncias Bioativas, Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Brazil.

This paper describes the synthesis and anti-inflammatory activity of new N-phenyl-phthalimide sulfonamides (3a-e) and the isosters N-phenyl-phthalimide amides (4a-e), designed as hybrids of thalidomide (1) and aryl sulfonamide phosphodiesterase inhibitor (2). In these series, compound 3e (LASSBio 468), having a sulfonyl-thiomorpholine moiety, showed potent inhibitory activity on LPS-induced neutrophil recruitment with ED(50)=2.5mg kg(-1), which was correlated with its inhibitory effect on TNF-alpha level.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010797 Phthalimides The imide of phthalic acids.
D001992 Bronchoalveolar Lavage Fluid Washing liquid obtained from irrigation of the lung, including the BRONCHI and the PULMONARY ALVEOLI. It is generally used to assess biochemical, inflammatory, or infection status of the lung. Alveolar Lavage Fluid,Bronchial Lavage Fluid,Lung Lavage Fluid,Bronchial Alveolar Lavage Fluid,Lavage Fluid, Bronchial,Lavage Fluid, Lung,Pulmonary Lavage Fluid,Alveolar Lavage Fluids,Bronchial Lavage Fluids,Bronchoalveolar Lavage Fluids,Lavage Fluid, Alveolar,Lavage Fluid, Bronchoalveolar,Lavage Fluid, Pulmonary,Lavage Fluids, Alveolar,Lavage Fluids, Bronchial,Lavage Fluids, Bronchoalveolar,Lavage Fluids, Lung,Lavage Fluids, Pulmonary,Lung Lavage Fluids,Pulmonary Lavage Fluids
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid

Related Publications

Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
January 2012, TheScientificWorldJournal,
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
April 2017, Bioorganic & medicinal chemistry letters,
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
May 2001, Die Pharmazie,
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
May 2005, Bioorganic & medicinal chemistry,
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
October 2020, Molecules (Basel, Switzerland),
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
February 2005, Bioorganic & medicinal chemistry letters,
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
January 2013, Bioorganic & medicinal chemistry letters,
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
September 2015, Molecules (Basel, Switzerland),
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
January 2019, Chemical & pharmaceutical bulletin,
Lídia M Lima, and Paulo Castro, and Alexandre L Machado, and Carlos Alberto M Fraga, and Claire Lugnier, and Vera Lúcia Gonçalves de Moraes, and Eliezer J Barreiro
January 2018, Mini reviews in medicinal chemistry,
Copied contents to your clipboard!